| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock, par value $0.001 per share | 48.4k | $0.00 | $0 | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Purchase | Common Stock, par value $0.001 per share | 71.8k | $4.00 | $287.2k | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series B Preferred Stock | 6.7M | $0.00 | $0 | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series C Preferred Stock | 4.6M | $0.00 | $0 | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series D Preferred Stock | 7.8M | $0.00 | $0 | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series E Preferred Stock | 807.7k | $0.00 | $0 | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock, par value $0.001 per share | 465.3k | $0.00 | $0 | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock, par value $0.001 per share | 273.5k | $0.00 | $0 | | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock, par value $0.001 per share | 399.2k | $0.00 | $0 | | 08/27/2013 |
| 04/06/2011 | Ocera Therapeutics, Inc. | OCRX | Conversion | Series A Convertible Preferred Stock | 15.3M | $0.00 | $0 | | 04/06/2011 |
| 04/06/2011 | Ocera Therapeutics, Inc. | OCRX | Purchase | Common Stock | 375k | $4.00 | $1.5M | | 04/06/2011 |
| 04/06/2011 | Ocera Therapeutics, Inc. | OCRX | Conversion | Common Stock | 2.2M | $0.00 | $0 | | 04/06/2011 |
| 06/05/2007 | AMICUS THERAPEUTICS, INC. | FOLD | Conversion | Common Stock | 1.1M | $0.00 | $0 | | 06/05/2007 |
| 06/05/2007 | AMICUS THERAPEUTICS, INC. | FOLD | Conversion | Common Stock | 354.9k | $0.00 | $0 | By Garden State Life Sciences Venture Fund, L.P. | 06/05/2007 |
| 06/05/2007 | AMICUS THERAPEUTICS, INC. | FOLD | Conversion | Series C Convertible Preferred Stock | 396.8k | $0.00 | $0 | | 06/05/2007 |
| 06/05/2007 | AMICUS THERAPEUTICS, INC. | FOLD | Conversion | Series C Convertible Preferred Stock | 132.3k | $0.00 | $0 | By Garden State Life Sciences Venture Fund, L.P. | 06/05/2007 |
| 06/05/2007 | AMICUS THERAPEUTICS, INC. | FOLD | Conversion | Series D Convertible Preferred Stock | 135.6k | $0.00 | $0 | | 06/05/2007 |
| 06/05/2007 | AMICUS THERAPEUTICS, INC. | FOLD | Conversion | Series D Convertible Preferred Stock | 45.2k | $0.00 | $0 | By Garden State Life Sciences Venture Fund, L.P. | 06/05/2007 |